Castleman's disease; Lymphoproliferation; Maladie de Castleman; Soft tissue tumor; Tumeur des tissus mous; Unicentric; Unicentrique; Humans; Female; Adult; Lymph Nodes/pathology; Biopsy; Mediastinum/pathology; Diagnosis, Differential; Castleman Disease/diagnosis; Castleman Disease/surgery; Castleman Disease/pathology; Lymph Nodes; Mediastinum; Pathology and Forensic Medicine
Abstract :
[en] [en] BACKGROUND: Castleman's disease is a rare and benign lymphoproliferative disorder which can be unicentric (UCD) or multicentric (MCD). UCD usually involves a single lymph node or less frequently a group of lymph nodes. The most common sites of nodal UCD presentation are the mediastinum, neck, abdomen and retroperitoneum. Rarely extranodal involvement has been reported. The intramuscular location is very unusual with only about 10 cases described in medical literature so far.
CASE REPORT: We present a case of atypical localization of Castleman's disease occurring in the right gluteal area in a 40-years-old female patient. The patient was asymptomatic and clinical examination was unremarkable except for a right gluteal palpable mass. The CT scanner-guided needle core biopsy was inconclusive. A surgical excision was then performed that revealed a hyaline-vascular type of Castleman's disease. The patient has an uneventful post-operative course.
CONCLUSION: The present case is instructive in the work-up of primary soft tissue tumors, for which Castleman's disease is extremely rare and not considered in the differential diagnosis of clinicians. Pathologists must be aware of its existence so that it can be evoked in the presence of a lymphoid population on histological examination.
Disciplines :
Hematology
Author, co-author :
Rizzo, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'anatomie et cytologie pathologiques
Camboni, Alessandra; Service d'anatomie et cytologie pathologiques, cliniques universitaires Saint-Luc, 1200 Bruxelles, Belgique
Van Eeckhout, Pascal; Service d'anatomie et cytologie pathologiques, cliniques universitaires Saint-Luc, 1200 Bruxelles, Belgique
Collins, Patrick ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Somja, Joan ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Language :
French
Title :
Localisation intramusculaire d’une maladie de Castleman unicentrique : cas clinique et revue de la littérature.
Alternative titles :
[en] Unusual gluteal localization of unicentric Castleman's disease: A case report and review of the literature.
Butzmann, A., Kumar, J., Sridhar, K., Gollapudi, S., Ohgami, R.S., A review of genetic abnormalities in unicentric and multicentric Castleman disease. Biology, 10, 2021, 251, 10.3390/biology10040251.
Chang, K.C., Wang, Y.C., Hung, L.Y., Huang, W.T., Tsou, J.H., Jones, M.D., et al. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Mod Pathol 6 (2014), 823–831, 10.1038/modpathol.2013.202.
Jeffrey Meideiros, L., Cesarman, E., Elenitoba-Johnson, K., et al. Tumour like lesions with B-cell predominance. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print], 2022, International Agency for Research on Cancer, Lyon (France) [cited 2023 03 15 (WHO classification of tumours series, 5th ed. vol. 11)] https://www.tumourclassification.iarc.who.int/chapters/63/283.
Sun, D.P., Chen, W.M., Wang, L., Wang, Z., Liang, J.H., Zhu, H.Y., et al. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases. J Cancer Res Clin Oncol 147 (2021), 2107–2115, 10.1007/s00432-020-03494-2.
Sevilla-Lizcano, D.B., Frias-Soria, C.L., Ortiz-Hidalgo, C., Castleman disease. Histopathological and immunohistochemical analysis of 39 cases. Gaceta Médica de México, 2017, 153.
Dong, Y., Wang, M., Nong, L., Wang, L., Cen, X., Liu, W., et al. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. Br J Haematol 169 (2015), 834–842.
van Rhee, F., Wong, R.S., Munshi, N., Rossi, J.F., Ke, X.Y., Fosså, A., et al. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol 9 (2014), 966–974, 10.1016/S1470-2045(14)70319-5.
Lee, E.S., Paeng, J.C., Park, C.M., Chang, W., Lee, W.W., Kang, K.W., et al. Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication. Clin Nucl Med 38 (2013), 339–342.
Akosman, C., Selcuk, N.A., Ordu, C., Ercan, S., Ekici, I.D., Oyan, B., Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment. Cancer Imaging 11 (2011), 52–55, 10.1102/1470-7330.2011.0011.